Sutter Health will be the first healthcare system in the Sacramento area to offer SAINT, a new accelerated version of ...
The FDA has approved the first at-home brain stimulation device for treating depression. Flow Neuroscience’s FL-100 delivers ...
SPRAVATO is the first FDA-approved nasal spray specifically for adults with treatment-resistant depression. Available with a ...
An in-home headset that allows people with depression to send mild electrical current to their brains has been cleared by the ...
FRIDAY, Dec. 12, 2025 (HealthDay News) — An at-home device that sends a gentle electrical current to the brain to help treat depression has been cleared by the U.S. Food and Drug Administration (FDA).
Midtown mental health clinic Radial Health, which offers less common treatments for mental illnesses, such as electromagnetic therapy and fast-acting medications, raised a $50 million Series A this ...
Introduction Cognitive impairment is a common consequence after stroke. Intermittent theta burst stimulation (iTBS) has emerged as a promising cognitive therapy. However, traditional iTBS typically ...
It was completely painless and so relaxing that I snoozed through the 30-minute procedure, and there’s no downtime. A course ...
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said it amended its Investigational New Drug filing for NRX-101 to include use of the drug in combination with ...
Hosted on MSN
NRx Pharmaceuticals (NASDAQ: NRXP) amends IND to advance NRX-101 with TMS for depression treatment
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback